E_mg_GB_03_vorne-29_3_04

More documents

Recommendations

Info

78 CONSOLIDATED BALANCE SHEETS at December 31, 2003 ASSETS Fixed Assets Note 12/31/2003 12/31/2002 u ’000 t ’000 Intangible assets 1 1,547,664 1,575,745 thereof goodwill e 1,482,392,000 (prior year: e1,494,531,000) Property, plant and equipment 1 1,412,206 1,381,669 Investments and long-term financial assets 1/5 131,160 148,513 Non-fixed assets 3,091,030 3,105,927 Inventories 3 618,016 628,611 Receivables and other assets 4 1,443,511 1,396,171 Securities 5 12,175 64,185 Cash and cash equivalents 6 171,952 165,291 2,245,654 2,254,258 Assets from discontinued operations G 466,151 556,931 Deferred taxes 20 867,760 748,947 Prepaid expenses 7 29,697 33,951 Total assets (thereof short-term 12/31/2003: e2,238,785,000; 12/31/2002: e2,252,325,000) 6,700,292 6,700,014 The accompanying notes are an integral part of these consolidated financial statements
MANAGEMENT SHARE STRATEGY SPECIAL SECTION MANAGEMENT REPORT FINANCIAL STATEMENTS FURTHER INFORMATION Consolidated Balance Sheets • Statements of Income • Statements of Cash Flows • Statements of Changes in shareholders’ Equity • Fixed Assets Schedule • Notes • Independent Auditors’ Report LIABILITIES AND SHAREHOLDERS’ EQUITY Shareholders' equity 8 Note 12/31/2003 12/31/2002 u ’000 t ’000 Capital stock 496,890 494,247 Additional paid-in capital 1,085,396 1,079,680 Retained earnings 523,977 442,823 Accumulated loss (prior year: unappropriated retained earnings) – 269,536 69,001 Accumulated other comprehensive loss – 172,966 – 94,579 1,663,761 1,991,172 Minority interests 9 41,141 42,006 Provisions and accrued liabilities 10 1,827,608 1,623,115 Liabilities 11 Financial liabilities 1,244,484 1,208,172 Other liabilities 1,394,305 1,309,963 2,638,789 2,518,135 Liabilities from discontinued operations G 429,657 408,386 Deferred taxes 20 61,870 66,604 Deferred income 12 37,466 50,596 Total liabilities excluding shareholders’equity 5,036,531 4,708,842 Total liabilities and shareholders’ equity thereof short-term 12/31/2003: e2,838,239,000; 12/31/2002: e2,533,680,000) 6,700,292 6,700,014 The accompanying notes are an integral part of these consolidated financial statements 79
Page 1 and 2:
“2003 was a year of transition fo
Page 3 and 4:
Consolidated Key Figures 2003 RESUL
Page 5 and 6:
Creating freedom for action CONTENT
Page 7 and 8:
MANAGEMENT SHARE STRATEGY SPECIAL S
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
zation As the world’s population
Page 27 and 28:
Page 29 and 30:
Page 31 and 32: MANAGEMENT SHARE STRATEGY SPECIAL S
Page 33 and 34: The pharmaceutical industry will co
Page 37 and 38: Milk Last year, over 160 million co
Page 39 and 40: The MODUL tablet press produced by
Page 45 and 46: For a technology-driven organizatio
Page 81: mg's mission is to ensure sustainab
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
MANAGEMENT AKTIE STRATEGIE SONDERTE
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185:
Key Figures for the mg Group RESULT
show all

E_mg_GB_03_vorne-29_3_04

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?